Am J Psychiatry 161:1110-1112, June 2004
© 2004 American Psychiatric Association
New Evidence of Association Between COMT Gene and Prefrontal Neurocognitive Function in Healthy Individuals From Sibling Pairs Discordant for Psychosis
Araceli Rosa, B.Sc., Ph.D.,
Víctor Peralta, M.D., Ph.D.,
Manuel J. Cuesta, M.D., Ph.D.,
Amalia Zarzuela, M.Sc.,
Fermín Serrano, M.D.,
Alfredo Martínez-Larrea, M.D., and
Lourdes Fañanás, B.Sc., M.D., Ph.D.
OBJECTIVE: Using a sample of sibling pairs discordant for psychosis, the authors attempted to replicate the findings of previous studies suggesting that the functional genetic polymorphism Val158Met in the catechol O-methyltransferase (COMT) gene influences prefrontal cognitive function and increases the risk for schizophrenia. METHOD: Eighty-nine sibling pairs discordant for psychosis were genotyped for this polymorphism and were assessed with the Wisconsin Card Sorting Test, a measure of prefrontal function. Additionally, the preferential transmission of alleles for this polymorphism was analyzed in a sample of 89 nuclear families in order to examine the genetic association. RESULTS: In the healthy siblings, a linear relationship was seen in which performance on the Wisconsin Card Sorting Test was associated in an allele dosage fashion with COMT genotype (i.e., fewer perseverative errors with higher number of methionine alleles). However, this association was not observed in patients. Furthermore, no evidence of genetic association with psychosis was detected. CONCLUSIONS: These results seem to confirm the role of COMT genotype in the modulation of executive functions related to frontal lobe function in healthy individuals but not in schizophrenia patients.
Related Article:
-
In This Issue
Am J Psychiatry 2004 161: A66.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
H. M. Haraldsson, U. Ettinger, B. B. Magnusdottir, T. Sigmundsson, E. Sigurdsson, A. Ingason, and H. Petursson
Catechol-O-Methyltransferase Val158Met Polymorphism and Antisaccade Eye Movements in Schizophrenia
Schizophr Bull,
June 17, 2008;
(2008)
sbn064v1.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. H. Barnett, J. Heron, S. M. Ring, J. Golding, D. Goldman, K. Xu, and P. B. Jones
Gender-Specific Effects of the Catechol-O-Methyltransferase Val108/158Met Polymorphism on Cognitive Function in Children
Am J Psychiatry,
January 1, 2007;
164(1):
142 - 149.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Raux, E. Bumsel, B. Hecketsweiler, T. van Amelsvoort, J. Zinkstok, S. Manouvrier-Hanu, C. Fantini, G.-M. M. Breviere, G. Di Rosa, G. Pustorino, et al.
Involvement of hyperprolinemia in cognitive and psychiatric features of the 22q11 deletion syndrome
Hum. Mol. Genet.,
January 1, 2007;
16(1):
83 - 91.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. M. Abdolmaleky, K.-h. Cheng, S. V. Faraone, M. Wilcox, S. J. Glatt, F. Gao, C. L. Smith, R. Shafa, B. Aeali, J. Carnevale, et al.
Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder
Hum. Mol. Genet.,
November 1, 2006;
15(21):
3132 - 3145.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Congdon and T. Canli
The endophenotype of impulsivity: reaching consilience through behavioral, genetic, and neuroimaging approaches.
Behav Cogn Neurosci Rev,
December 1, 2005;
4(4):
262 - 281.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. Breier
Developing Drugs for Cognitive Impairment in Schizophrenia
Schizophr Bull,
October 1, 2005;
31(4):
816 - 822.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. C. Stefanis, J. van Os, D. Avramopoulos, N. Smyrnis, I. Evdokimidis, and C. N. Stefanis
Effect of COMT Val158Met Polymorphism on the Continuous Performance Test, Identical Pairs Version: Tuning Rather Than Improving Performance
Am J Psychiatry,
September 1, 2005;
162(9):
1752 - 1754.
[Abstract]
[Full Text]
[PDF]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 2004
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
